Guidance on format of the RMP in the EU in integrated format
4
0
0
Texto
Documentos relacionados
IMPORTANT POTENTIAL RISKS Applicable for [Duloxetine] 30/ 60 mg strength products and [Duloxetine] 20/ 40 mg strength products Risk What is known Including reason why it is